4至7岁儿童使用破伤风-白喉(Td)疫苗:世界卫生组织专家咨询会
为终身预防白喉和破伤风,世界卫生组织(WHO)推荐六剂含白喉和破伤风疫苗。Td疫苗目前获批用于7岁及以上人群,但用于4岁及以上对许多中低收入国家免疫规划有利。WHO召开专家咨询会审查4至7岁使用Td疫苗的现有证据,结论认为从规划角度,在六剂系列中作为第二剂加强针在4至7岁接种Td可提供足够保护,并建议将这一年龄扩展变更纳入说明书。
要点
- 专家咨询会认为4至7岁儿童与7岁以上儿童相比免疫应答无相关生物学差异。
- 多项研究显示4至7岁年龄组接种Td疫苗或联合疫苗有足够血清保护。
- 专家建议将4至7岁接种Td作为六剂系列第二剂加强针纳入说明书年龄扩展。
核心结论
- 从规划角度看,在4至7岁接种Td疫苗作为六剂系列中的第二剂加强针可提供足够的白喉和破伤风保护。
- 专家建议采取措施将这一年龄扩展变更列入说明书。
研究设计与样本
- 世界卫生组织(WHO)召开专家咨询会,审查4至7岁儿童使用Td疫苗的现有证据。
主要发现
- 相关年龄组与7岁以上儿童相比免疫应答无相关生物学差异。
- 多项研究显示4至7岁年龄组使用Td疫苗以及许多使用联合疫苗的研究中有足够的血清保护。
- 多项纵向和模型研究显示至少9至11年的持久保护性应答。
- 与使用全剂量白喉疫苗相比反应原性更低,可能改善接种体验。
- 若干国家在4至7岁儿童中使用含Td联合疫苗对白喉有足够控制。
关键数值与推荐
- WHO推荐六剂含白喉和破伤风疫苗以终身预防白喉和破伤风。
- Td疫苗(白喉类毒素减量,≥2-5 IU)目前获批用于7岁及以上年龄。
- 专家建议将4至7岁接种Td作为六剂系列第二剂加强针的年龄扩展变更列入说明书。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
For lifetime protection against diphtheria and tetanus, the World Health Organization (WHO) recommends six doses of diphtheria and tetanus containing vaccines. Td (reduced diphtheria toxoid, ≥2-5 IU) vaccines are currently licensed for ages 7 years and older, but use of Td vaccine for ages 4 years and older would have advantages for immunization programs in many low- and middle-income countries. For this reason, WHO convened an expert consultation to review the currently available evidence for the use of Td vaccine from 4 to 7 years of age which concluded: (1) no relevant biological difference in immune response in the relevant age group compared with children over 7 years of age; (2) adequate seroprotection in several studies with Td vaccine in the 4-7 age group and many studies using combination vaccines; (3) durable and protective response of at least 9-11 years duration in several longitudinal and modelling studies, (4) less reactogenicity compared with use of full-dose diphtheria vaccine, potentially improving the vaccination experience; and (5) adequate control of diphtheria in several countries using Td-containing combination vaccines in 4-7 year old children. On this basis, the experts concluded that from a programmatic perspective, Td vaccine given in ages 4-7 years, as a second booster dose in a six-dose series, would provide adequate protection against diphtheria and tetanus and recommended steps to include this change in age extension listed in the package insert.
引用
- Desai S, Scobie HM, Cherian T, et al. Use of tetanus-diphtheria (Td) vaccine in children 4-7 years of age: World Health Organization consultation of experts. Vaccine. 2020. PMID: 31983584. doi:10.1016/j.vaccine.2020.01.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。